Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation
Clinical trial NCT00633321 · COMPLETED
Trial details
- NCT number
- NCT00633321
- Sponsor
- Celtic Pharma Development Services
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-12-01
- Enrollment
- 522
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.